A localized Gram-negative bacterial infection in otherwise healthy individuals is rapidly resolved due to effective recruitment of leukocytes and in the early phase primarily neutrophils. By contrast, systemic, Gram-negative septicemia continues to elude effective therapy with 50% mortality, i.e., the death of ϳ200,000 people a year in North America (1, 2) . In these cases, it is the inappropriate activation of inflammatory processes including inappropriate leukocyte infiltration into tissues that causes the progression to uncontrolled whole body inflammation (3) . It is thought that a major contributor to 1) localized infections as well as 2) the morbidity associated with systemic infections is the shedding of LPS from Gram-negative bacteria into the circulation (4) .
Leukocyte recruitment has generally been described as a multistep cascade involving endothelial selectins (E-and P-selectin) and leukocyte selectins (L-selectin) which permit the initial phase of leukocyte recruitment, namely transient attachment to the endothelial surface followed by leukocyte rolling along the vessel wall (5, 6) . The second phase of leukocyte recruitment involves the activation of integrins that mediate firm adhesion (5, 7) . In many local inflammatory conditions, including, e.g., ischemia/reperfusion of the mesentery or muscle, immunoneutralization of one or more selectins completely inhibited leukocyte rolling and therefore prevented leukocyte recruitment (8 -10) . Interestingly, using identical antiselectin approaches to try to inhibit LPS-induced leukocyte recruitment has proved to be far more challenging. Although we were able to delay leukocyte rolling and subsequent adhesion in mesentery with antiselectins, ultimately, inhibition of one of the integrins (␣ 4 integrin) was also necessary to prevent all leukocyte adhesion in response to LPS (11) . Further complexity was identified in tissues like liver and lung where adhesion molecule inhibitor regimen did not reduce leukocyte adhesion in response to LPS (12) (13) (14) .
Therefore, from a therapeutic viewpoint, due to the multitude of known as well as to date unidentified adhesion mechanisms that are evoked with LPS, antiadhesion therapy may not be a viable approach to limiting leukocyte sequestration in endotoxemia. However, interruption of the initiating signal perhaps at the level of the LPS receptor could conceivably inhibit the multitude of adhesion molecules that are activated and limit the untoward sequestration of leukocytes in the lungs as well as other vascular beds. CD14 is considered the main LPS receptor, present both as a soluble form in blood or as a membrane-bound form in myeloid lineage cells. Indeed, CD14
Ϫ/Ϫ mice are at least 100 times more resistant to LPS-induced mortality, and their macrophages also have greatly reduced responsiveness as assessed by TNF-␣ and IL-1 production (15) . Because CD14 is a GPI-anchored protein devoid of a transmembrane domain, by itself, it presumably cannot transmit the activating signal into the cell. Indeed, in vitro work has demonstrated that Toll-like receptor 4 (TLR4) 3 activates the immune system by functioning as a transmembrane coreceptor to CD14 (16, 17) . Both TLR4-deficient (TLR4 d ) mice and mice with a single point mutation at aa 712 (proline to histidine) in the TLR4 gene (C3H/HeJ) are resistant to the immunostimulatory and pathophysiological effects of LPS (18, 19) . Clearly, it seems reasonable to hypothesize that altered leukocyte-endothelial cell interactions observed in lungs and other tissues in response to LPS would be entirely dependent on CD14 and associated TLR4.
Only a few studies have focused on the role CD14 and TLR4 in leukocyte sequestration. Based on initial work by Haziot et al. (15) , CD14-deficient mice had reduced dissemination of Gram-negative bacteria. These investigators went on to discover that CD14-deficient mice as well as TLR4 mutant mice had an early and intense sequestration of neutrophils into the peritoneum, which was absent in wild-type mice. This was unexpected in light of the lack of responsiveness of these mutant mice to LPS. Therefore, we decided to systematically compare and contrast the role of CD14 and TLR4 in local and systemic LPS-induced leukocyte-endothelial cell interactions in vivo in numerous organs using two specialized techniques. First we used an in vivo assay system to visualize and study leukocyte behavior within a number of microvasculatures before and after LPS. Second, we used a sensitive, quantitative in vivo adhesion molecule expression system to examine endothelial responsiveness to LPS in all organs of CD14 Ϫ/Ϫ and TLR4 d mice. We show that TLR4 d mice are completely resistant to LPS administration as it pertains to leukocyte-endothelial responses. By contrast, we identified that in some but not all microvascular beds partial endothelial responsiveness (protein expression and leukocyte function) to LPS was noted in CD14 Ϫ/Ϫ mice.
Materials and Methods

Mice
Mice deficient in CD14 were generated by gene targeting in embryonic stem cells as previously described (15) and were backcrossed on a BALB/c background to the 10th generation. Wild-type BALB/c mice (CD14 ϩ/ϩ ) (The Jackson Laboratory, Bar Harbor, ME) were used as controls for the CD14 Ϫ/Ϫ mice. TLR4 d mice (C3H/HeJ mice) were obtained from The Jackson Laboratory. Wild-type C3H/HeN mice (TLR4 ϩ/ϩ ) (Charles River Laboratories, Montreal, Quebec, Canada) were used as controls for TLR4 d mice. All mice weighed between 20 and 35 g and were between 6 and 10 wk of age at the time of use.
Intravital microscopy
Mice were anesthetized by i.p. injection of a mixture of xylazine hydrochloride (10 mg/kg; MTC Pharmaceuticals, Cambridge, Ontario, Canada) and ketamine hydrochloride (200 mg/kg; Rogar/STB, London, Ontario, Canada). The jugular vein was cannulated and used to administer additional anesthetic, fluorescent dyes, and various drugs. Animals were then prepared for viewing of either the skeletal muscle microcirculation (20) or the dermal microcirculation (21) as previously reported by our laboratory. Cremaster muscle preparation. The cremaster muscle was dissected free of tissues and exteriorized onto an optically clear viewing pedestal. The muscle was cut longitudinally with a cautery and held flat against the pedestal by attaching silk sutures to the corners of the tissue. The muscle was then superfused with bicarbonate-buffered saline (pH 7.4). Skin flap preparation. A midline dorsal incision was made. The skin was carefully separated from the underlying tissue, remaining attached laterally. Blood supply to the skin flap remained intact. The skin flap was then extended over a viewing pedestal, secured along the edges using 4-0 suture, exposing the dermal microvasculature. The exposed skin was continuously superfused with bicarbonate-buffered saline to avoid tissue dehydratation. Due to the thickness of the skin flap, leukocyte-endothelial cell interactions were not visible by transillumination. Therefore, for this protocol, animals were injected with the fluorescent dye, rhodamine 6G (0.3 mg/kg i.v.; Sigma-Aldrich, St. Louis, MO), immediately before microscopic visualization. Rhodamine 6G at the dose used labels leukocytes and platelets, allows detection of the same number of rolling leukocytes as transmitted light, and has no effect on leukocyte kinetics (22) . Rhodamine 6G-associated fluorescence was visualized by epi-illumination at 510-560 nm using a 590-nm pore size emission filter (22) .
The cremaster and dermal microcirculations were observed through an intravital microscope with a ϫ10 eyepice (Axioskop; Carl Zeiss Canada, Don Mills, Ontario, Canada), a ϫ25 objective lens for cremaster, and a ϫ40 objective lens for skin. A video camera (5100 HS; Panasonic, Osaka, Japan) for the cremaster preparation and a fluorescent camera (model C-2400-08; Hammamatsu Photonics, Hammamatsu City, Japan) for the skin preparation were used to project the images onto a monitor, and the images were recorded for playback analysis using a videocassette recorder. 
Quantitation of endothelial activation
To determine the degree of endothelial activation two endothelial adhesion molecules (P-selectin and VCAM-1) known to contribute to leukocyte recruitment in endotoxemia were measured. Expression of the adhesion molecules P-selectin and VCAM-1 were quantified using a modified dualradiolabeled Ab technique (21, 24) . The Abs RB40.34 (against P-selectin) and 429 (MVCAM.A) (against VCAM-1) were labeled with 125 I. The Abs A110-1 (a rat IgG1, isotype standard) and R35-95 (a rat IgG2a, isotype control Ig) were labeled with 131 I. In both cases, the Abs were labeled using the IodoGen method, as previously described (21, 24) . A110-1 and R35-95 were used to detect nonspecific binding in the murine system.
To study P-selectin, animals were injected i.v. with a mixture of 10 g 125 I-anti-labeled P-selectin (RB40.34), and a variable dose of 131 I-labeled nonbinding Ab (A110-1). To measure VCAM-1, mice were injected with 10 g 125 I-labeled anti-VCAM-1 (429 (MVCAM.A)), 25 g unlabeled anti-VCAM-1 (429 (MVCAM.A)), and a variable dose of 131 I-labeled nonbinding Ab (R35-95) calculated to achieve a total injected 131 I activity of 400,000 -600,000 cpm (total volume, 200 l). This Ab combination was chosen after pilot experiments, conducted over a range of doses of unlabeled 429 (MVCAM.A), showed that this protocol ensured receptor saturation under stimulated conditions. In both cases, the Abs were allowed to circulate for 5 min; then the animals were heparinized. A blood sample was obtained from a carotid artery catheter; then the mice were exsanguinated by blood withdrawal through the carotid artery catheter and simultaneous i.v. infusion with bicarbonate-buffered saline. The lung, muscle, heart, brain, small bowel, large bowel, skin, pancreas, and liver were harvested and weighed. Both 131 I and 125 I activities were measured in plasma and tissue samples.
P-selectin and VCAM-1 expression was calculated per gram of tissue, by subtracting the accumulated activity of the nonbinding Ab ( 131 I-labeled Ab) from the accumulated activity of the binding Ab ( 125 I-labeled Ab). Data for P-selectin and VCAM-1 were presented as the percentage of the injected dose of Ab per gram of tissue. It has been previously demonstrated that this approach provides reliable quantitative values of adhesion molecule expression and that radiolabeled binding Ab can be displaced specifically with sufficient amounts of unlabeled Ab. The technique is sufficiently sensitive that very small, basal levels of P-selectin can be detected in wild-type mice relative to P-selectin-deficient mice where values are zero (24, 25) .
Determination of tissue myeloperoxidase (MPO) activity
At the end of each experiment, samples of the lung were weighed, frozen on dry ice, and processed for determination of MPO activity. MPO is an enzyme found in cells of myeloid origin and has been used extensively as a biochemical marker of granulocyte (mainly neutrophil) infiltration into the lung (26, 27) . The samples were stored at Ϫ20°C for no more than 1 wk before the MPO assay was performed. MPO activity was determined using an assay described previously, with the volumes of each reagent modified for use in 96-well microtiter plates (28) . Change in OD 450 during a 90-s period was determined using a kinetic microplate reader (Molecular Devices, Sunnyvale, CA).
Circulating leukocyte counts
At the end of each experiment, whole blood was drawn via cardiac puncture. Total leukocyte counts were performed, using a Bright-line hemocytometer (Hausser Scientific, Horsham, PA).
Experimental protocol
First, CD14
Ϫ/Ϫ , TLR4 d , and their respective wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ) were prepared for intravital microscopy, and the microcirculations were examined for leukocyte-endothelial cell interactions under basal conditions. Circulating leukocyte counts as well as pulmonary MPO levels were also measured at the end of each experiment. Local LPS administration. In all experiments, LPS from Escherichia coli 0111:B4 dissolved in nonpyrogenic water was added to 0.2 ml saline. This LPS is highly purified with Ͻ0.0008% of contaminating bacterial proteins (15, 29) . In these studies, LPS was administered locally by s.c. injection beneath the scrotal skin using a 30-gauge needle. Animals were returned to their cages for 3.5 h. The right cremaster muscle was then prepared for intravital microscopy and leukocyte-endothelial cell interactions, and hemodynamic parameters in single postcapillary venules were examined. Preliminary experiments indicated that local administration of 0.05 g/kg LPS was optimal for examination of leukocyte-endothelial interaction. To examine an LPS-independent inflammatory response, the effect of local administration of TNF-␣ (0.5 g) was examined in all mouse strains. Systemic (i.p.) LPS administration. Mice received 0.5 mg/kg (ϳ12.5 g/ mouse) of the highly purified LPS i.p. This dose was chosen to avoid any mortality over the study period even after anesthesia. Moreover, preliminary dose-response studies revealed that higher doses of LPS administered i.p. resulted in stagnant peripheral microvasculatures. In one set of experiments, we analyzed the expression of P-selectin adhesion molecule in different mouse organs induced by LPS after 4 h treatment by using a dual-radiolabeled Ab technique. To examine the peripheral microvasculature directly, the dorsal skin or the cremaster muscle was prepared for visualization by intravital microscopy and observed for 60 min between 3.5 and 4.5 h post-LPS administration. In all cases, LPS-induced leukocyte sequestration was examined in CD14 Ϫ/Ϫ , TLR4 d , and their respective wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ).
Statistical analysis
All data are displayed as mean Ϯ SEM. All data were analyzed using Student's t test, and a Bonferroni correction was applied where multiple comparisons were necessary. A value of p Ͻ 0.05 was deemed significant.
Results
TLR4 d and CD14-deficient mice are completely resistant to the effects of local LPS in the cremaster microcirculation
First we chose to examine a normal inflammatory response to local LPS administration (0.05 g/kg). This concentration of LPS had absolutely no effect on hemodynamic parameters (data not shown) but induced profound changes in leukocyte-endothelial cell interactions in wild-type mice (Fig. 1) . In untreated vessels of all four groups of mice (BALB/c (CD14
, ϳ50 -100 leukocytes can be seen rolling through postcapillary venules every min (Fig. 1A) . These cells roll at relatively high velocities (40 -80 m/s) (Fig. 1B) . Fewer than three cells are seen adhering (Fig. 1C) in the postcapillary venules. Local administration of LPS into muscle significantly decreased leukocyte rolling velocity in the muscle postcapillary venules of wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ), suggesting activation of the local vasculature in these mice (Fig.  1B) . Interestingly, absolutely no change in the rolling velocity of leukocytes was noted in postcapillary venules of CD14 Ϫ/Ϫ and TLR4 d mice (Fig. 1B) . The flux of rolling leukocytes was not altered by the dose of LPS used in this study (Fig. 1A) . Unlike local LPS, one feature of systemic LPS is a profound drop in both the circulating leukocytes and the flux of rolling leukocytes (later section) in wild-type mice. Ϫ/Ϫ and TLR4 Ϫ/Ϫ mice in response to local LPS administration. To confirm that leukocyte-endothelial cell interactions can be induced in CD14 Ϫ/Ϫ and TLR4 d mice in response to other inflammatory mediators, TNF-␣, an inflammatory mediator that acts independent of the LPS-CD14 interaction, was examined. Table I reveals that intrascrotal injection of TNF-␣ affected leukocyte-endothelial cell interactions in CD14 Ϫ/Ϫ , TLR4 d , and their respective wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ) in a similar way. Local TNF-␣ induced in both mutant and wild-type mice a classical significant decrease (80%) in the leukocyte rolling velocity and an increase in leukocyte adhesion and emigration. Local administration of TNF-␣ induced similar changes in leukocyte rolling flux in TLR4 d and wild-type mice and in CD14 Ϫ/Ϫ and their respective wild-type mice (data not shown).
Hemodynamic parameters in response to systemic LPS
In preliminary data, we observed profound reductions in blood flow using concentrations of LPS higher than 0.5 mg/kg i.p. Therefore, we chose 0.5 mg/kg (ϳ12.5 g/mouse) LPS, which induces leukocyte sequestration without affecting hemodynamic parameters including venular diameter, RBC velocity, and calculated wall shear rates ( Table II) . Venules between 25 and 35 m were chosen in all groups of animals. RBC velocity was ϳ2.0 -3.5 mm/s, and the calculated shear rate (based on velocity and diameter) also did not increase or decrease with LPS administration during the first 4 h. Therefore, hemodynamic changes were not a confounding factor of leukocyte sequestration with systemic LPS administration.
Effects of systemic LPS on circulating leukocytes
We analyzed circulating leukocyte counts in CD14 ϩ/ϩ , CD14 Ϫ/Ϫ , TLR4 ϩ/ϩ , and TLR4 d mice under baseline conditions. As shown in Fig. 2A , there are no differences in baseline circulating leukocyte counts among the different mice. Systemic LPS induced a profound drop in the number of circulating leukocytes in wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ). Circulating lymphocytes, neutrophils, and monocytes were decreased (data not shown). This decrease was perhaps in part a result of a significant increase in the number of leukocytes sequestered into the lungs as assessed by pulmonary MPO activity (Fig. 2B) . In contrast, neither CD14 Ϫ/Ϫ nor TLR4 d mice responded to systemic LPS, i.e., circulating leukocyte counts remained unchanged in both groups of animals before and after LPS treatment (Fig. 2A) . The role of CD14 and TLR4 in leukocyte sequestration in the lungs was examined because they are primary target organs in sepsis. Lung MPO increased 2-to 3-fold in both strains of animals in response to systemic LPS administration, whereas no response was noted in CD14 Ϫ/Ϫ and TLR4 d mice (Fig. 2B) . The 8-to 10-U/mg tissue of MPO increase in lung suggests that the majority of circulation neutrophils were sequestered in this organ.
Endothelium from CD14
Ϫ/Ϫ but not TLR4 d mice showed P-selectin increase induced by systemic LPS Leukocyte recruitment into peripheral tissues is dependent on the ability of the endothelium to express selectins to allow for leukocyte rolling followed by subsequent integrin-dependent leukocyte adhesion. P-selectin expression was used as a marker of endothelial activation in all vasculatures of wild-type and mutant mice, because this molecule was previously shown to be an important selectin in endotoxin-induced leukocyte sequestration (11, 14) . Figs. 3 and 4 demonstrate a 20-to 50-fold increase in P-selectin expression in all wild-type mouse tissues (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ) tested. The organs are divided into CD14-dependent (Fig.  3 ) and CD14-independent (Fig. 4 
) LPS responses. In CD14
Ϫ/Ϫ mice, there were no increases in P-selectin expression in lung in response to LPS consistent with a lack of leukocyte sequestration into this organ (Fig. 3A) . No increase in endothelial P-selectin expression was detected in response to LPS in muscle, heart, brain, small bowel, or large bowel (Fig. 3, B-F) . In surprising contrast, a consistent and significant increase in P-selectin expression was observed in the skin (4-fold) and pancreas (7-fold) of CD14 Ϫ/Ϫ mice (Fig. 4) . Interestingly, all organs of TLR4 d mice remained completely unresponsive to LPS (Figs. 3  and 4) . Although the majority of leukocytes roll via P-selectin at 4 h LPS, a second endothelial molecule (VCAM-1) was also elevated in CD14 Ϫ/Ϫ mice (Fig. 5) . Again no increase in VCAM-1 expression in response to LPS was detected in TLR4 d mice, whereas an increase in VCAM-1 expression was detected in a number of tissues including pancreas (Fig. 5A) , heart, liver, and large bowel (data not shown). Surprisingly, a small amount of VCAM-1 was even detected in muscle and lung, which could impact on mononuclear cell sequestration at later times (Fig. 5, B and C) but not on the 4-h leukocyte sequestration. Fig. 5D shows that some tissues, e.g., small intestine, had no VCAM-1 up-regulation in CD14 Ϫ/Ϫ mice. However, VCAM-1 appeared to be up-regulated in more tissues than P-selectin. a Mice were treated with local TNF-␣, 0.5 g, for 4 h. At this time, the cremasteric postcapillary venules were visualized by intravital microscopy. Data are expressed as the arithmetic mean Ϯ SEM from three mice in each group. a Mice were treated with 0.5 mg/kg LPS i. p. for 3.5 h. At this time for 1 h, the cremasteric postcapillary venules were visualized by intravital microscopy. Data are expressed as the arithmetic mean Ϯ SEM at 1h from four or five mice in each group.
TLR4 d but not CD14 Ϫ/Ϫ mice are completely resistant to the effects of systemic LPS in the skin microcirculation
To assess whether the organ-specific, differential adhesion molecule responsiveness in different microvasculatures translated to altered leukocyte function, we directly visualized leukocyte trafficking in skin and muscle postcapillary venules using intravital microscopy. LPS induced in both wild-type mice (CD14 ϩ/ϩ and TLR4 ϩ/ϩ ), a Ͼ90% reduction in leukocyte rolling flux within the skin (Fig. 6A) , which may reflect our work (Fig. 2) and previous reports of leukocytopenia (3, 13) . By contrast, LPS did not alter the flux of rolling cells in either CD14
Ϫ/Ϫ or TLR4 d mice treated with LPS (Fig. 6A) . The velocity of leukocyte rolling is indicative of increased tether upon the leukocyte by activated endothelium (expression of selectins and chemokines). A very significant reduction in leukocyte rolling velocity was noted in CD14 ϩ/ϩ mice (Fig.  6B) . If LPS had no impact in skin vasculature of CD14 Ϫ/Ϫ mice, no reduction in rolling velocity would be expected. However, in CD14 Ϫ/Ϫ mice, the velocity of rolling cells was significantly reduced, indicating that the endothelium was activated in CD14 Ϫ/Ϫ skin postcapillary venules (Fig. 6B) . No decrease in rolling velocity was seen in TLR4 d skin postcapillary venules. In the two strains of wild-type mice, leukocyte adhesion increased 5-to 6-fold (Fig.   6C ). Most importantly, a significant increase in leukocyte adhesion was noted in CD14 Ϫ/Ϫ mice (Fig. 6C ) consistent with the increased adhesion molecule expression in skin microvasculature. The latter responses were completely absent in TLR4 d mice (Fig.  6C ) consistent with the view that TLR4 is absolutely essential in LPS signaling even in tissues where CD14 was not needed.
TLR4
d and CD14-deficient mice are completely resistant to the effects of systemic LPS in the cremaster microcirculation Next, we examined leukocyte trafficking in the muscle microvasculature wherein no endothelial activation (no P-selectin) was detected in CD14 Ϫ/Ϫ or TLR4 d mice stimulated with LPS. Under basal conditions, ϳ50 -100 cells/min rolled through microvessels (Fig. 7A) . By contrast after LPS treatment, we noted that both CD14 ϩ/ϩ and TLR4 ϩ/ϩ mice had a profound reduction in leukocyte rolling flux within the cremaster (Fig. 7A) , similar to that seen in the skin. The velocity of leukocyte rolling, which is indicative of local endothelial activation, was reduced by 95% in both wildtype mice strains after 4 h LPS administration (Fig. 7B ). In contrast, neither the flux of rolling cells nor the velocity of these cells was altered in either CD14
Ϫ/Ϫ or TLR4 d mice, suggesting that the endothelium was not activated in the postcapillary venules of these mice. It is interesting that in the muscle postcapillary venules, very few cells ultimately adhered in response to systemic LPS (Fig. 7C ) in either wild-type or the mutant mouse strains. Only a 2-to 3-fold increase in adhesion was noted perhaps due to less effective synthesis of proinflammatory molecules (chemokines, etc.) in the muscle vasculature. The same scale is used as in Fig. 1C , highlighting the far more effective adhesion of leukocytes in local (Fig.  1 ) than in systemic (Fig. 7) LPS. Regardless, the data in Fig. 7   FIGURE 5 . VCAM-1 expression in pancreas, muscle, lung and small intestine in CD14 Ϫ/Ϫ , TLR4 d and their wild-type mice respectively. Mice were treated with 0.5 mg/kg LPS i.p. for 4 h. After this time, VCAM-1 expression was quantified using a modified dual-radiolabeled Ab technique (Materials and Methods). Data are expressed as the arithmetic mean Ϯ SEM from five mice in each group. ‫,ء‬ p Ͻ 0.01 vs untreated mice. ϩ/ϩ and TLR4 ϩ/ϩ , respectively. Data are expressed as the arithmetic mean Ϯ SEM from five mice in each group. ‫,ء‬ p Ͻ 0.01 vs untreated mice. ‫,ء‬ , In TLR4 ϩ/ϩ , no rolling was seen at 4.5 h, but small amounts of rolling were seen at early time points. demonstrate significant changes in leukocyte behavior (rolling, rolling velocity) in wild-type but not CD14 Ϫ/Ϫ mice in muscle, whereas responsiveness was noted in skin (Fig. 6 ).
Discussion
In this study, we examined the importance of CD14 and TLR4 in leukocyte-endothelial cell responses to LPS in various microcirculations. First, in the absence of CD14 and TLR4, there was no endothelial activation or neutrophil sequestration into lungs or skeletal muscle. However, in CD14 Ϫ/Ϫ mice, endothelial activation was apparent after systemic LPS treatment albeit in only a limited number of organs. Surprisingly, in CD14 Ϫ/Ϫ mice, there was a significant increase in P-selectin expression in skin and pancreas. This was not specific for P-selectin as partial VCAM-1 expression was also noted in a number of additional organs in CD14 Ϫ/Ϫ mice. Moreover, this translated into functional output in the skin microcirculation of CD14 Ϫ/Ϫ mice; leukocyte rolling velocity was notably reduced, and leukocyte adhesion was significantly enhanced. By contrast, none of these responses were observed in TLR4 d mice. These results suggest that the neutrophil sequestration to some tissues is entirely dependent on both CD14 and TLR4 but that there are CD14-independent, TLR4-dependent endothelial cell responses in other microvascular beds.
There are numerous reports to suggest that inhibition of adhesion molecules in lungs is not sufficient to prevent leukocyte accumulation into this tissue (12, 13) . This is thought to be due to physical trapping of activated leukocytes within this microvascular bed due to the more narrow architecture of pulmonary capillaries (26, 27) . Wang et al. (30) have reported that the endothelium increases in rigidity and perhaps contributes to the physical trapping of the general circulating pool of leukocytes. There may also be a direct increase in leukocyte rigidity in response to LPS and thereby increased sequestration within the pulmonary microvascular bed (30) . Clearly, it is not surprising that some studies have reported only partial or no decrease in LPS-induced leukocyte sequestration with anti-adhesion therapy (13, 31) . In this study, we for the first time have identified a genetic intervention (CD14 Ϫ/Ϫ or TLR4 d ) that completely prevents any systemic LPS-induced leukocyte sequestration into the pulmonary microvasculature. Clearly, LPS stimulates the CD14 and TLR4 complex, which activates both leukocytes and endothelium to induce adhesion and/or physical trapping within the pulmonary microvasculature.
Although at least 10 TLRs have been identified, TLR2 and TLR4 have received the most attention as recognition receptors of distinct bacterial cell wall components and more specifically LPS (19, 32) . Much evidence suggests that TLR4 is the dominant LPS TLR. Initial work demonstrated that LPS stimulated NF-B-mediated gene expression in HEK 293 cells only when those cells were transfected with TLR4 cDNA (33) . Mouse strains that lacked functional TLR4 (C3H/HeJ and C57BL/10ScCr) revealed resistance to LPS assessed as a lack of cytokine production and no mortality (18) . More recently, TLR4
Ϫ/Ϫ mice showed hyporesponsiveness to LPS to an extent similar to that of C3H/HeJ mice (19) . Although TLR2 was initially also thought to function as an LPS receptor, this was likely a result of contaminant found in commercial LPS preparations (29, 34) . Current evidence argues against a major role for TLR2 in the physiological response to LPS (19, 35, 36) . For example, TLR2
Ϫ/Ϫ mice have normal cytokine profiles and a similar degree of mortality in response to LPS (19) . Our study examined leukocyte-endothelial cell interactions directly with highly purified LPS, and the data support the view that TLR2 is not involved in LPS-induced leukocyte sequestration inasmuch as in the absence of functional TLR4 there was no detectable sequestration of leukocytes or endothelial activation. Clearly, our data are in agreement that TLR4 is the only TLR involved in LPS-mediated leukocyte-endothelial cell interactions.
Although the majority of work regarding TLR4 and CD14 has been performed in isolated macrophages, which are definitely activated during endotoxemia, it is quite likely that the early vascular responses to LPS occur via a direct effect of LPS on endothelium. Indeed, LPS will rapidly activate endothelium to induce synthesis of proadhesive molecules that sequester leukocytes independent of macrophages (37) . Although endothelium also expresses TLR4 (38 -40) , unlike monocytes and neutrophils, endothelium is thought not to constitutively express membrane CD14 (41) (42) (43) (44) . However, this cell will respond to LPS via a soluble form of CD14 (sCD14) present in blood (45) (46) (47) (48) . Therefore, in the presence of plasma proteins, endothelium has all of the machinery necessary to rapidly respond to LPS and synthesize P-selectin, E-selectin, VCAM-1, and ICAM-1 as well as chemokines to induce leukocytes to roll, adhere, and ultimately emigrate into tissues. Our data would suggest that much like macrophages, endothelium responds to LPS exclusively via TLR4 to induce leukocyte sequestration.
Although this is to our knowledge the first report of LPS-induced leukocyte sequestration via a CD14-independent, TLR4-dependent pathway, a number of in vitro studies support this view. For example, Tsan et al. (49) reported that LPS was unable to induce TNF and manganese superoxide dismutase in isolated, CD14
Ϫ/Ϫ peritoneal macrophages at low concentrations but could induce TNF and manganese superoxide dismutase at higher concentrations of LPS. Similar concentration-dependent findings have been reported in peritoneal macrophages for TNF message and for certain LPS-inducible genes including IL12 (p35 and p40) and COX-2 (50) . Finally, in the original study by Haziot et al. (15) , CD14 Ϫ/Ϫ mice produced no cytokines at 20 mg/kg LPS but could produce IL-6 but not TNF at 200 mg/kg. To avoid concentrationdependent effects, we used 0.5 mg/kg LPS in this study (400-fold less), which did not induce cytokine production in CD14 Ϫ/Ϫ mice (15) yet in the dermal microcirculation induced an increase in leukocyte-endothelium interactions. One could argue that, because we injected LPS i.p., CD14
Ϫ/Ϫ peritoneal macrophages were exposed to relatively high concentrations of LPS, inducing release of cytokines that would have activated distal vasculatures. However, this seems very unlikely because 1) we used 400-fold less LPS than is required to induce cytokine production from CD14 Ϫ/Ϫ macrophages, 2) no systemic signs of inflammation including a drop in circulating leukocytes were noted, and 3) the activation was site specific, i.e., occurred in skin but not muscle or lung.
Interestingly, TLR4 d mice were resistant to LPS responses that occurred independent of CD14. For example, TLR4 d mice were resistant to the increase in P-selectin expression in all the tested organs; in the skin microcirculation, TLR4 d mice were completely devoid of leukocyte effects in response to systemic LPS (Fig. 6) . Clearly, our data suggest a very sensitive second CD14-independent, TLR4-dependent pathway of leukocyte sequestration. The selectivity of this mechanism in skin rather than lung or muscle may reflect LPS-binding proteins on dermal endothelium or extravascular cells (dermal macrophages, fibroblasts, keratinocytes) that have evolved alternative LPS detection systems.
Potential candidates as substitutes for CD14 include ␤ 2 integrins (CD11/CD18), the macrophage scavenger receptor and L-selectin, which have all been proposed to bind LPS and activate cells (51) (52) (53) . However, to our knowledge, none of these molecules is expressed in significant amounts on endothelium. Very recently, heat shock proteins 70 and 90, chemokine receptor 4, and growth differentiation factor 5 have been reported to form a CD14-independent activation cluster after LPS ligation and are involved in LPS signal transduction (54) . However, no mention of a need for TLR4 was made in that study. Finally, new reports indicate that MD-2 is a genuine LPS-binding protein in a manner that is independent of the assistance by either LPS-binding protein or CD14 (55) (56) . Like CD14, MD-2 has no transmembrane domain and apparently remains cell associated because it binds to TLR4 (57). Although extremely difficult to test in vivo, MD-2 may be a likely candidate to mediate significant CD14-independent, TLR4-dependent leukocyte-endothelial cell responses to LPS. However, this type of mechanism may be less likely to be organ specific, unless different vasculatures display different levels of MD-2 and TLR4.
In this study, we have for the first time described in vivo an LPS-induced leukocyte sequestration via a CD14-independent, TLR4-dependent pathway in skin. In addition, we have reported that the absence of CD14 or TLR4 prevents any leukocyte sequestration into the lungs and muscle. Thus, taken together, our results suggest that there are CD14-dependent and CD14-independent responses to LPS, but in both cases the responses are dependent on the presence of TLR4, suggesting that other proposed LPS receptors besides CD14 likely require TLR4 in the leukocyte sequestration response.
